|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS10091 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-OPG |
| 克隆性 | |
| 靶點(diǎn) | 詳見(jiàn)說(shuō)明書 |
| 適應(yīng)物種 | 詳見(jiàn)說(shuō)明書 |
| 形態(tài) | 詳見(jiàn)說(shuō)明書 |
| 宿主 | 詳見(jiàn)說(shuō)明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human OPG intermedial |
技術(shù)外包服務(wù):
★骨保護(hù)蛋白/護(hù)骨素抗體品牌 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
實(shí)驗(yàn)流程：
骨保護(hù)蛋白/護(hù)骨素抗體品牌 英文名稱 Anti-OPG
中文名稱 骨保護(hù)蛋白/護(hù)骨素抗體品牌
別 名 MGC29565; OCIF; OPG; Osteoclastogenesis Inhibitory Factor; TNFRSF 11B; TNFRSF11B; TR 1; TR1; Tumor Necrosis Factor Receptor Superfamily Member 11b; TR11B_HUMAN.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Cow
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 骨髓細(xì)胞
蛋白分子量 predicted molecular weight: 43kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human OPG intermedial
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
骨保護(hù)蛋白/護(hù)骨素抗體品牌 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Osteoprotegerin (OPG, or osteoclastogenesis inhibitory factor) is a secretory glycoprotein belonging to TNF receptor superfamily. Acts as decoy receptor for RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis. Bone homeostasis seems to depend on the local RANKL/OPG ratio. May also play a role in preventing arterial calcification. May act as decoy receptor for TRAIL and protect against apoptosis. TRAIL binding blocks the inhibition of osteoclastogenesis. OPG acts as a soluble factor in the regulation of bone mass and may be beneficial in the treatment of osteoporosis with increased osteoclast activity. OPG consists of 401 amino acids with a molecular weight of 44 kDa as a monomer and 90 kDa as a disulphide-linked dimer.
Function : Acts as decoy receptor for RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local RANKL/OPG ratio. May also play a role in preventing arterial calcification. May act as decoy receptor for TRAIL and protect against apoptosis. TRAIL binding blocks the inhibition of osteoclastogenesis.
Subunit : Homodimer.
Subcellular Location : Secreted.
Tissue Specificity : Highly expressed in adult lung, heart, kidney, liver, spleen, thymus, prostate, ovary, small intestine, thyroid, lymph node, trachea, adrenal gland, testis, and bone marrow. Detected at very low levels in brain, placenta and skeletal muscle. Highly expressed in fetal kidney, liver and lung.
Post-translational modifications : N-glycosylated. Contains sialic acid residues.
The N-terminus is blocked.
DISEASE : Defects in TNFRSF11B are the cause of juvenile Paget disease (JPD) [MIM:239000]; also known as hyperostosis corticalis deformans juvenilis or hereditary hyperphosphatasia or chronic congenital idiopathic hyperphosphatasia. JPD is a rare autosomal recessive osteopathy that presents in infancy or early childhood. The disorder is characterized by rapidly remodeling woven bone, osteopenia, debilitating fractures, and deformities due to a markedly accelerated rate of bone remodeling throughout the skeleton. Approximately 40 cases of JPD have been reported worldwide. Unless it is treated with drugs that block osteoclast-mediated skeletal resorption, the disease can be fatal.
Similarity : Contains 2 death domains.
Contains 4 TNFR-Cys repeats.
Database links :
UniProtKB/Swiss-Prot: O00300.3
Entrez Gene: 4982 Human
Omim: 602643 Human
SwissProt: O00300 Human
Unigene: 81791 Human
護(hù)骨素又稱護(hù)骨因子(osteorotegenin,OPG)、骨保護(hù)蛋白、破骨細(xì)胞生成抑制因子、骨保護(hù)素、破骨細(xì)胞抑制生成因子（osteoclastogenesis inhibitory factor，OCIF）
OPG屬于TNF受體超家族，主要功能是抑制破骨細(xì)胞的分化、成熟破骨細(xì)胞的骨吸收活性，并誘導(dǎo)其凋亡。
全、新、優(yōu)、品、好四大特點(diǎn)：
骨保護(hù)蛋白/護(hù)骨素抗體品牌 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品：
Fbg ELISA Kit 大鼠血纖蛋白原Multi-class antibodies規(guī)格： 48T
Anti-5-HT/FITC 熒光素標(biāo)記5-羥色胺抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh FOP/FGFR1OP FGFR1癌基因伴侶蛋白抗體 規(guī)格 0.2ml
TREM-1 ELISA Kit 大鼠髓系細(xì)胞觸發(fā)受體-1 96T
MAZ 英文名稱： 鋅指蛋白801抗體 0.1ml
AF 4 protein 英文名稱： 原癌基因AF4蛋白抗體 0.2ml
Anti-5-HT/FITC 熒光素標(biāo)記5-羥色胺抗體IgGMulti-class antibodies規(guī)格： 0.2ml
HGH human 人生長(zhǎng)激素Multi-class antibodies規(guī)格： 48T
Anti-Collagen II Ⅱ型膠原抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh Nonylphenol 壬基酚抗體 規(guī)格 1ml
Human High mobility group protein B1,HMGB-1 ELISA Kit 人高遷移率族蛋白B1 96T
TP53TG5 英文名稱： p53靶蛋白5抗體 0.2ml
CEP104 英文名稱： 中心體蛋白104抗體 0.2ml
Anti-Collagen II Ⅱ型膠原抗體Multi-class antibodies規(guī)格： 0.1ml
LH ELISA Kit 大鼠促黃體激素Multi-class antibodies規(guī)格： 48T
Anti-ATP-sensitive K+ channel subunit Kir6.2/FITC 熒光素標(biāo)記ATP敏感性通道亞基kir6.2抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh FABP5 脂肪酸結(jié)合蛋白5抗體(上皮細(xì)胞型) 規(guī)格 0.1ml
CDl4(Human cluster Of differentiation) ELISA Kit 人CD14分子 96T
MICA 英文名稱： MHC I類鏈相關(guān)蛋白A/組織相容性復(fù)合物MHCIa抗體 0.1ml
ACTR 英文名稱： 絲酸/蘇酸蛋白激酶ATR抗體 0.1ml
Anti-ATP-sensitive K+ channel subunit Kir6.2/FITC 熒光素標(biāo)記ATP敏感性通道亞基kir6.2抗體IgGMulti-class antibodies規(guī)格： 0.2ml
SHH Protein Human 重組人 SHH / Sonic hedgehog 蛋白 (aa 198-462, His 標(biāo)簽)
LOVO 人細(xì)胞
CD80 Others Mouse 小鼠 CD80 / B7-1 / CD28LG 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
MCF7 [MCF-7]人癌細(xì)胞 MCF7 human breast cancer cell line [MCF-7] 1640+10% FBS
小鼠細(xì)胞;B16-F1
人皮膚成纖維細(xì)胞;CCC-HSF-1 B16-F10, 小鼠高轉(zhuǎn)移細(xì)胞 Mouse
CL-0305SF-295(人XG惡性細(xì)胞)5×106cells/瓶×2
PDGFRB Others Rat 大鼠 PDGFRB / PDGFR-1 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人脈絡(luò)叢內(nèi)皮細(xì)胞總RNAHCPEC NA
MDA-MB-453細(xì)胞，人導(dǎo)管癌細(xì)胞 鼠細(xì)胞系,B82細(xì)胞 膀胱平滑肌細(xì)胞Many types of cells包裝：5 × 105次方(1ml)
SMC-1(人胸膜瘤細(xì)胞) 5×106cells/瓶×2
HPAEC Pellet 人肺動(dòng)脈內(nèi)皮細(xì)胞團(tuán)塊 > 1 mio.cells 心肌細(xì)胞生長(zhǎng)添加物CMGS
骨保護(hù)蛋白/護(hù)骨素抗體品牌 SHH Protein Human 重組人 SHH / Sonic hedgehog 蛋白 (aa 198-462, His 標(biāo)簽)
LOVO 人細(xì)胞
CD80 Others Mouse 小鼠 CD80 / B7-1 / CD28LG 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
MCF7 [MCF-7]人癌細(xì)胞 MCF7 human breast cancer cell line [MCF-7] 1640+10% FBS
小鼠細(xì)胞;B16-F1
人皮膚成纖維細(xì)胞;CCC-HSF-1 B16-F10, 小鼠高轉(zhuǎn)移細(xì)胞 Mouse
|
|
|
|
